Superior Quality. Superior Service.
Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide showing potent effects on glucose regulation and weight reduction. It represents a new class of incretin-based therapeutics under investigation.
Application: Metabolic disease research, obesity and diabetes modeling, preclinical drug candidate evaluation, neuroendocrine function studies
| Size | Price | |
| 1 mg | $85.00 | |
| 10 mg | $147.00 | |
| 50 mg | $330.00 | |
| 100 mg | $495.00 | |